The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Presenilin 2 influences miR146 level and activity in microglia
Abstract
Microglia, the resident innate immune cells of the CNS, are the primary defenders against microbes and critical to CNS remodeling. Dysregulation of microglial behavior can lead to unchecked pro‐inflammatory activity and subsequent neurodegeneration. The molecular mechanisms leading to chronic inflammation and microglial dysfunction in neurodegenerative diseases are not well‐understood. It is known that patients with Presenilin 2 (PS 2) mutations develop autosomal dominant Alzheimer disease. We have shown that a lack of normal PS 2 function is associated with exaggerated microglia pro‐inflammatory responses in vitro. To identify pathways by which PS 2 regulates microglia and determine how PS 2 dysfunction may lead to altered inflammatory pathways, we pursued an unbiased array approach to assess differential expression of micro RNA s between murine PS 2 knockout (KO) and wild‐type microglia. We identified miR146, a negative regulator of monocyte pro‐inflammatory response, as constitutively down‐regulated in PS 2 KO microglia. Consistent with a state of miR146 suppression, we found that PS 2 KO microglia express higher levels of the miR146 target protein interleukin‐1 receptor‐associated kinase‐1, and have increased NF κB transcriptional activity. We hypothesize that PS 2 impacts microglial responses through modulation of miR146a. PS 2 dysfunction, through aging or mutation, may contribute to neurodegeneration by influencing the pro‐inflammatory behavior of microglia. image Presenilin 2 (PS2), a membrane associated protease, has been implicated in the pathogenesis of Alzheimer disease. We have previously shown that PS2 plays an important role in curbing the proinflammatory response in microglia. Here, we report the novel finding that PS2 participates in maintaining the basal and cytokine induced expression of the innate immunity regulating microRNA, miR146. These data suggest one mechanism by which PS2 works to reign in proinflammatory microglial behavior and that PS2 dysfunction or deficiency could thus result in unchecked proinflammatory activation contributing to neurodegeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“LPS induced an upregulation of miR-146a in BV-2 and EOC 13.31 microglial cell lines (43), as well as in primary microglia cells (44).”
From Absence of miRNA-146a Differentially Alters Microglia Function and Proteome (2020) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Signaling in innate immunity and inflammation
Newton, K., & Dixit, V. M. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a006049 · Cited by 1,513
Shen, J., & Kelleher, R. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608332104 · Cited by 485
miR-146a Is Critical for Endotoxin-induced Tolerance
Nahid, M. A., Pauley, K. M., Satoh, M., & Chan, E. K. L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.056317 · Cited by 423
Cruchaga, C., Chakraverty, S., Mayo, K., Vallania, F. L. M., Mitra, R. D., Faber, K., Williamson, J., Bird, T., Diaz-Arrastia, R., Foroud, T. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031039 · Cited by 320
Research works printed but not linked: 34
- 10.1126/science.1227901 · DOI · Paper page
- 10.1016/S0092-8674(04)00045-5 · DOI
- 10.1074/jbc.M409544200 · DOI
- 10.1084/jem.20101823 · DOI · Paper page
- 10.1126/science.271.5252.1128 · DOI
- 10.1016/S0896-6273(03)00205-8 · DOI · Paper page
- 10.1016/j.bcp.2010.06.020 · DOI
- 10.3233/JAD-2011-101065 · DOI · Paper page
- 10.1016/j.semcdb.2008.11.014 · DOI
- 10.3233/JAD-2010-1414 · DOI
- 10.1016/j.molmed.2011.06.002 · DOI · Paper page
- 10.4049/jimmunol.0900707 · DOI · Paper page
- 10.1371/journal.pone.0015743 · DOI
- 10.1093/brain/awq033 · DOI
- 10.1111/j.1474-9726.2011.00757.x · DOI
- 10.1016/S0070-2153(10)92006-1 · DOI
- 10.1016/j.it.2012.05.002 · DOI · Paper page
- 10.1038/nrm1406 · DOI
- 10.1212/WNL.47.2.425 · DOI · Paper page
- 10.1128/MCB.05821-11 · DOI
- 10.4161/rna.4.3.5206 · DOI
- 10.1097/00001756-200505120-00015 · DOI
- 10.1146/annurev-immunol-020711-075013 · DOI · Paper page
- 10.1038/nri2957 · DOI
- 10.4049/jimmunol.180.8.5689 · DOI · Paper page
- 10.1002/glia.22363 · DOI · Paper page
- 10.1038/nature09615 · DOI · Paper page
- 10.1016/S0002-9440(10)61159-5 · DOI
- 10.4049/jimmunol.164.8.4301 · DOI
- 10.1073/pnas.0605298103 · DOI · Paper page
- 10.1016/B978-0-12-394816-8.00004-0 · DOI
- 10.1073/pnas.0707755105 · DOI
- 10.1073/pnas.1105398108 · DOI · Paper page
- 10.1074/jbc.M112.349738 · DOI
Cited by
Sorted by citations
The Future of Precision Medicine in the Cure of Alzheimer’s Disease
Arafah, A., Khatoon, S., Rasool, I., Khan, A., Rather, M. A., Abujabal, K. A., Faqih, Y. A. H., Rashid, H., Rashid, S. M., Bilal Ahmad, S., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11020335 · Cited by 133
Upstream regulators and downstream effectors of NF-κB in Alzheimer’s disease
Shi, Z.-M., Han, Y.-W., Han, X.-H., Zhang, K., Chang, Y.-N., Hu, Z.-M., Qi, H.-X., Ting, C., Zhen, Z., & Hong, W. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.05.022 · Cited by 125
Absence of miRNA-146a Differentially Alters Microglia Function and Proteome
Martin, N. A., Hyrlov, K. H., Elkjaer, M. L., Thygesen, E. K., Wlodarczyk, A., Elbaek, K. J., Aboo, C., Okarmus, J., Benedikz, E., Reynolds, R., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01110 · Cited by 36
Aluminum-induced molecular neurodegeneration: The protective role of genistein and chickpea extract
Wahby, M. M., Mohammed, D. S., Newairy, A. A., Abdou, H. M., & Zaky, A. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.05.044 · Cited by 35
Metadata
- Authors
- Jayadev, S., Case, A., Alajajian, B., Eastman, A. J., Möller, T., & Garden, G. A.
- Affiliations
- Department of Neurology University of Washington Medical Center Seattle Washington USA
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2013-09-30
- Volume
- 127
- Issue
- 5
- Pages
- 592-599
- ISSN
- 0022-3042
- 1471-4159
- PMC
- PMC4346352
- Cited by
- 62
- References
- 4
- Language
- en
- Funders
- Core Center of Excellence in Hematology (R01NS072395, RAG08083, R01NS073848, P30HD02274, DK56465-P30)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review